• Home
  • Contact
  • About
  • Team
  • Vaccines & Technology
  • News & Events
  • Investors
  • Partners
  • Careers
  • Media Releases
  • In the News
  • Upcoming Events

Media Releases


  • 2008 Releases
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006

Oct 1 -  ImmunoVaccine Technologies’ DepoVax™ Shows Positive Results for Cancer and Infectious Diseases

Sep 30 -  ImmunoVaccine Technologies selected as Canada's Top 10™ Life Sciences Companies

Aug 5 -  ImmunoVaccine Technologies Broadens Its Patent Protection to Japan

Jun 26 -  Warwick Kimmins Science Scholarship Awarded

Jun 16 -  International Convention to Showcase Atlantic Canada's Contributions to Biotechnology Innovation

Jun 5 -  Bioject and ImmunoVaccine Technologies Announce Research Collaboration

Jun 2 -  ImmunoVaccine Technologies Unveils Warwick Kimmins Science Scholarship

Apr 30 -  ImmunoVaccine Technologies Patents DepoVax™ Vaccine Platform

Feb 20 -  ImmunoVaccine Technologies Appoints The Honourable Michael Kirby as Chair

Jan 23 -  ImmunoVaccine Technologies Discusses Phase I Clinical Trial Application

Jan 21 -  ImmunoVaccine Technologies Receives $3 Million from ACOA

Jan 14 -  ImmunoVaccine Technologies licenses the VacciMax® platform to Pfizer Animal Health for future animal vaccine applications

Disclaimer

1819 Granville Street, Suite 303, Halifax, Nova Scotia, B3J 3R1     Tel: 902.492.1819     Fax: 902.492.0888

© 2009 ImmunoVaccine Technologies. All rights reserved.